CLINICAL_TRIALS
trial_result
· 2011-12-26
Clinical Trial Update: Low Dose Decitabine + Interferon Alfa-2b in Advanced Renal Cell Carcinoma [Phase 2]
Summary
Phase 2 trial evaluating low-dose decitabine plus interferon alfa-2b in advanced renal cell carcinoma was terminated, with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: M.D. Anderson Cancer Center | Conditions: Renal Cell Carcinoma | Phase 2 | Status: TERMINATED | Results posted: 2011-12-26